VAERS Reports UJ573ABA

VAERS 2595227

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ573ABA

mild

Staat: CA
Alter: 0,3
Geschlecht: M
Eingang: 09.03.2023
Impfdatum: 28.12.2021
Beginn: 28.12.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Rash

Symptomtext

Client, 4 month old, received Pediarix( DtaP, Ipv, Hep B), PCV13, and Hib. No reaction observed at the time when vaccine given. Mother of child reported that client started with rash on torso, arms and legs. No respiratory distressed observed. Symptoms re-evaluated and rash started to diminish. EMT called per clinic protocol. Transferred care at the time of arrival.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2590296

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ573ABA

gering

Staat: MA
Alter: -
Geschlecht: M
Eingang: 02.03.2023
Impfdatum: 24.02.2023
Beginn: 24.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered

Symptomtext

patient received extra dose of IPV received Pentacel and IPV on same day

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2203574

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ573ABA

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 29.03.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Medication error No adverse event Product preparation error

Symptomtext

vaccine has been diluted to a regular sterile water instead of the diluent associated with the vaccine with no reported adverse events; Initial information received on 17-Mar-2022 regarding an unsolicited valid non-serious case received from an other health professional. This case involves an unknown age and unknown gender patient who was administered Haemophilus type B (HIB) vaccine [ACT-HIB] which has been diluted to a regular sterile water (water for injection) instead of the diluent associated with the vaccine with no reported adverse events. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a 0.5 ml dose, of suspect HIB (PRP/T) vaccine, once (with an unknown formulation, strength (standard) and route) (lot number: UJ573ABA and expiry date: 20-Sep-2022) diluted with sterile water in unknown administration site for immunization. On an unknown date the patient was administered HIB (PRP/T) vaccine which had been diluted to a regular sterile water instead of the diluent associated with the vaccine with no reported adverse events (product preparation error) (same day latency). Action taken was not applicable with both the suspects. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: WATER FOR INJECTION
Allergien: -
Vorherige Impfungen: -